A previous report has shown that hyperexcitation caused by BCC resulted in activation of type I mGluR1/5 and that a cocktail of noncompetitive mGluR1/5 inhibitors could prevent postsynaptic downscaling of AMPARs (Hu et al., 2010). The gene discussed is GRM1; the disease is skin basal cell carcinoma.